# New Animal Drugs; Change of Sponsor; Change of Sponsor Address; Azaperone; Miconazole, Polymyxin B, and Prednisolone Suspension
> **Food and Drug Administration** · Final rule. · Published 2012-08-06 · Effective 2012-08-06 · 77 FR 46612
## Document
- **Document number:** 2012-19147
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 77 FR 46612
- **CFR reference:** 21 CFR 510
- **Publication date:** 2012-08-06
- **Effective date:** 2012-08-06
- **HHS docket:** Docket No. FDA-2012-N-0002
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for two new animal drug applications (NADAs) from Janssen Pharmaceutica NV, to Elanco Animal Health, a Division of Eli Lilly & Co. FDA is also amending the animal drug regulations to reflect a change of sponsor's address for Veterinary Service, Inc.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2012/08/06/2012-19147/new-animal-drugs-change-of-sponsor-change-of-sponsor-address-azaperone-miconazole-polymyxin-b-and)
---
*AI Analytics · CC0 1.0*